Hi Everywherman! I was hoping you could answer a couple of quick questions for me since you seem very competent on Inovio and you also attended the conference. First, what was your take on the reaction the scientific community had regarding the results at the conference? Were they let down by the regression rates or excited about the T-cell response and other factors beyond my scope? Also, I'm your opinion what do you think the chances are that VGX-3100 will go to phase 3? If they do, how long do you think we would have to wait to get word from the FDA that we did get approval for phase 3? That's it! Thanks for your help! I read all your entries and even watch your Dr. Kim interview. Thanks for all your guidance!